Prospective validation identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition;İki metabolik sendrom taniminin kardiyometabolik risk öngörüs_n_dsun ayni kohortta prospektif yolla deǧerlendirilmesi ve halkimiz için en uygun tanimin seçilmesi

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue 1, 2007, Pages 29-34

  Onat, Altan ^a,b,d   Hergenç, Gülay ^c   Can, Günay ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b YILDIZ TECHNICAL UNIVERSITY   (Turkey)

^c Biyoloji Bölümü   (Turkey)

^d NONE   (Turkey)

Author keywords

Adult treatment panel III definition; Atherogenic dyslipidemia; Coronary heart disease risk; Metabolic syndrome; Risk assessment type 2 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETOGENESIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PREDICTION; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC); WAIST CIRCUMFERENCE; ABDOMINAL FAT; BLOOD; COHORT ANALYSIS; CORONARY ARTERY DISEASE; HOSPITALIZATION; MIDDLE AGED; OBESITY; PATHOLOGY; PROSPECTIVE STUDY; REPRODUCIBILITY; VALIDATION STUDY;

ABDOMINAL FAT; ADULT; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 34047217049     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
2. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006; 47: 1093-100.
3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus; provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
4. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new world-wide definition. Lancet 2005; 366:1059-62.
5. Onat A, Ceyhan K, Başar Ö, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 165: 285-92, 2002.
6. Onat A, Hergenç G, Türkmen S, Yazici M, Sari I, Can G. Discordance between Insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism 2006; 55: 445-52.
7. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2006; May 7; [Epub ahead of print].
8. Onat A, Sari I, Hergenç G, Yazici M, Can G, Uyarel H, et al. Predictors of and consequences in relation to the degree of abdominal obesity among Turkish women: a prospective population-based study. (In press 2007)
9. Onat A, Sansoy V, Hergenç G, Soydan I, Adalet K. Halkimiza ilişkin temel veri üretiminden evrensel tibba katkiya. In: Onat A, editör. Türk Erişkinlerinde Kelp Saǧliǧi: Istanbul; Argos Iletişim: 2005. s. 166.
10. Hense HW, Stieber J. Blutdruck-Messkurs. Heidelberg; GSF-MEDIS Institut: 1988.
11. Onat A, Avci GŞ, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes 2004; 28:1018-25.
12. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26: 3160-7.
13. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods, 2nd edition. Geneva, WHO, 1982. p 124-27.
14. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-7.
15. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as a predictor of type 2 diabetes: the San Antonio Heart study. Diabetes Care 2003; 26: 3153-9.
16. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CH, Golden SH, et al. The Atherosclerosis Risk in Communities investigators. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 2005; 28: 2013-8.
17. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart study. Circulation 2004; 110:1251-7.
18. Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesaniemi YA, Mahley RA, et al. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol 2005; 95: 194-8.
19. Onat A, Sansoy V. Halkimizda koroner hastaliǧin başsuçlusu metabolik sendrom: koroner risk ile ilişkisi ve yüksek risk kriterleri. Türk Kardiyol Dern Arş 2002; 30; 8-15.
20. Türk Kardiyoloji Derneǧi Koroner Kalp Hastaliǧi Korunma ve Tedavi Kilavuzu. TKD Yayinlari, Istanbul; Yenilik Basimevi: 2003. s 13.
21. Onat A, Sari I, Yazici M, Can G, Hergenç G, Avci GŞ: Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome. Int J Candiol 2006; 108: 89-95.